DENVER, Feb. 16, 2022 /PRNewswire/ -- DaVita Kidney Care today announced Dr.
Mihran Naljayan as chief medical
officer (CMO) of Home Modalities.
Dr. Naljayan joined DaVita in 2016 and most recently served as
vice president of clinical affairs within DaVita's home dialysis
program. In that role, he created and led DaVita's home physician
support network—a program that helps empower nephrologists to
advocate for home dialysis with eligible patients. Since Dr.
Naljayan joined DaVita, there has been a 35% increase in home
hemodialysis and peritoneal dialysis treatments. He will continue
to lead this initiative while expanding his scope as CMO of Home
Modalities.
"Dr. Naljayan is a relentless innovator with a bold vision for
at-home kidney care, including helping to increase equitable access
to home dialysis for our patients," said Dr. Jeff Giullian, CMO for DaVita Kidney Care. "With a proven track record,
we know he'll continue to help expand and improve DaVita's
capabilities as a comprehensive kidney care provider."
Dr. Naljayan succeeds Dr. Martin
Schreiber, who has led DaVita's home dialysis program since
2014. Dr. Schreiber will continue to serve DaVita's home patients
in a part-time capacity as a consultant for several strategic
initiatives, including DaVita's 11 newly launched value-based care
programs that aim to increase access to home dialysis.
"I have deep gratitude for the countless physicians and patients
Dr. Schreiber has inspired to become advocates for home
treatments," said Dr. Naljayan. "It's an honor to build on the
foundation he set and further support physicians and patients who
want to experience the benefit of treating at home."
Dr. Naljayan is board certified in nephrology and hypertension
through the American Board of Internal Medicine. He completed
medical school at the Louisiana State
University School of Medicine in Shreveport, Louisiana, followed by his
internal medicine residency and nephrology fellowship at Beth
Israel Deaconess Medical Center, a teaching hospital of
Harvard Medical School in Boston. He is a Clinical Associate Professor
at LSU School of Medicine in New
Orleans.
More information about how DaVita is transforming care for
patients who choose to treat at home is available
at DaVita.com/Home.
About DaVita Inc.
DaVita (NYSE: DVA) is a
comprehensive kidney care provider focused on transforming care to
improve the quality of life for patients globally. The company is
one of the largest providers of kidney care services in the U.S.
and has been a leader in clinical quality and innovation for more
than 20 years. DaVita is working to help increase equitable access
to care for patients at every stage and setting along their kidney
health journey—from slowing progression of kidney disease to
streamlining the transplant process, from acute hospital care to
dialysis at home. As of December 31,
2021, DaVita served 203,000 patients at 2,815 outpatient
dialysis centers in the U.S. The company operated an additional 339
outpatient dialysis centers in ten countries worldwide. DaVita has
reduced hospitalizations, improved mortality and worked
collaboratively to propel the kidney care community to adopt an
equitable, high-quality standard of care for all patients,
everywhere. To learn more, visit DaVita.com/About.
* Service provider and modality selection are
choices made exclusively between the patient and
nephrologist.
Contact Information
Media:
Halie Peddle
Halie.Peddle@DaVita.com
(303) 550-6349
View original content to download
multimedia:https://www.prnewswire.com/news-releases/davita-kidney-care-appoints-new-chief-medical-officer-of-home-modalities-301483293.html
SOURCE DaVita Kidney Care